Multilateral organizations in conjunction with the FDA must do more to expose the problem of counterfeit drugs and help countries tighten regulatory controls.

The possibility of a grand bargain that would produce major trade liberalization in manufacturing, services and agriculture has steadily diminished and has now disappeared.

While India is blamed for counterfeiting crucial drugs, a vast Chinese network behind the fakes is getting away.

We are at a political impasse in the fight against fake drugs.

The United States is one of a few nations that hasn't ratified CEDAW, but a closer look at the content shows that the Senate has been wise to resist for 31 years.

The majority of the antimalarial products on sale in Kenya are neither brands nor generics but copy products of unknown provenance and variable quality.

China's squeeze on rare minerals is a subtle means of putting pressure on an advanced society, and Japan and her allies must work now to counter such resource bullying, or risk being victimized in the future.

Fake drugs kill thousands of people each day, thanks to counterfeiters in China and India who mix chalk, dust, and dirty water into pills sold around the world.